]>
IRCT20141209020258N137 IRCT 2020-03-15 Arak University of Medical Sciences A study comparing the effectiveness of pomegranate versus Gabapentin for treatment of Diabetic nephropathy in patients of diabetus melitus type A study comparing the effectiveness of pomegranate versus Gabapentin for treatment of Diabetic nephropathy in patients of diabetus melitus type 2 2013-08-01 anticipated 74 Complete https://irct.ir/trial/45561 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple individual randomization with randomization with envelopes in two groups A and B.‏ In this method, we selected a number of cards or letters as an intervention group and the same ‎number of cards for the control group, then the cards were merged. One card was taken out and its ‎allocation was registered and the card was returned to the other cards after leaving. Then the cards ‎are merged again and we remove another card. This process continues to reach a random sequence ‎according to sample size, Blinding description: This study is double blind. Researcher who complete questionnaire and analyzer are blind (double blind). Outcome assessor and analyzer don't aware from grouping.The person evaluating the outcome is unaware of the grouping. Groups A and B are available to analyzer and outcome assessor. 2-3 Type 2 diabetes. Intervention 1: Intervention group: In the pomegranate medicine group, patients are given pomegranate tablet (225 milligram - Amin.Co Iran)half pills every 12 hours for 3 months. Intervention 2: Intervention group: Patients in Gabapentin group were also given a 300 milligram tablet every 8 hours for 3 months. Yes - There is a plan to make this available What will be shared: When we publish article in journal When: After the article is published To whom: Researcher in university Conditions: If there are additional questions Where to obtain: Dr Javad Tabaeean How to obtain: They have to write letters to the professors and the university Comments:
public Dr Javad Tabaeyan
Valiasr hospital, Valiasr squre, Shahid Shirodi street, Arak
Arak Iran (Islamic Republic of) 3814957558 +98 634173638 Tabaeean@arakmu.ac.ir Arak University of Medical Sciences scientific Dr Javad Tabaeyan
Valiasr hospital, Valiasr squre, Shahid Shirodi street, Arak
Arak Iran (Islamic Republic of) 3814957558 +98 634173638 Tabaeean@arakmu.ac.ir Arak University of Medical Sciences Iran (Islamic Republic of) Patients with type 2 diabetes who have painful lower extremity nephropathy for at least 3 months Age between 70 and 30 years Do not take pomegranate pills. Do not have severe physical, neurological or psychiatric illness. Do not become pregnant or breast-feeding. 30 years 70 years Both Severe sensitivity to pomegranate pills Severe grade 4 heart failure or unstable angina HbA1c greater than or equal to 8.5 E08 Diabetes mellitus due to underlying condition Treatment - Drugs Treatment - Drugs Intervention group: In the pomegranate medicine group, patients are given pomegranate tablet (225 milligram - Amin.Co Iran)half pills every 12 hours for 3 months. Intervention group: Patients in Gabapentin group were also given a 300 milligram tablet every 8 hours for 3 months. Lower extremity nephropathy. Timepoint: Start and 3 months after intervention. Method of measurement: Examination. Arak University of Medical Sciences Approved 2013-07-31 Ethics comittee of Arak University of Medical Sciences Ethics comittee, Research center, Payambar Azam complex, Basij squre , Sardasht, Arak Arak Markazi Iran (Islamic Republic of)